Robert T Jennings

Address:

1502 Wisconsin Ave, Oceanside, CA 92054

Phone:

(760)9361743

VIN:

1G6DJ5EV4A0100509

Make:

CADILLAC

Model:

CTS

Year:

2010

US Patent:

6578476, Jun 17, 2003

Filed:

Mar 5, 2001

Appl. No.:

09/800374

Inventors:

Thomas A. Liguori - Poway CA
Robert T. Jennings - San Diego CA

Assignee:

TLCD Corporation - San Diego CA

International Classification:

B41F 1708

US Classification:

101 401, 101488

Abstract:

A system and process for placing printed color images on a series of objects including: generating digital data representing a plurality of different color images; providing a print medium composed of a substrate carrying a releasable coating which is formulated to retain printing inks; supplying the generated digital data to a digitally controlled color printer having a plurality of print heads; feeding the print medium through the printer while operating the print heads under control of the generated data; and placing a portion of the printed coating in contact with an objects and transferring the image to the object. The printed medium may be incorporated into a mold. Alternatively, this may be accomplished by: providing a digitally controlled color printer having a plurality of print heads; feeding the objects to be printed upon past the printer; and operating the print heads under control of the generated digital data to print the color images on the objects.

US Patent:

8008255, Aug 30, 2011

Filed:

May 28, 2004

Appl. No.:

10/559595

Inventors:

John Ong - San Marcos CA, US
Robert Jennings - San Diego CA, US
Gregg Stetsko - San Diego CA, US

Assignee:

Amylin Pharmaceuticals, Inc. - San Diego CA

International Classification:

A61K 38/00
A61K 38/22
A61K 38/26
C07K 14/00
C07K 14/575
C07K 14/605

US Classification:

514 117, 514 11, 514 12, 514 72, 530300, 530308, 530324

Abstract:

Provided are methods and compositions for enhancing the transmucosal absorption of bioactive peptides and proteins. More particularly, the invention provides compositions for enhancing the transmucosal absorption of bioactive peptides and proteins, such as exendin-4, PYY, PYY, and GLP-1 and their analogs and derivatives, wherein the compositions comprise an absorption enhancing mixture of a cationic polyamino acid and a buffer that is compatible with the polyamino acid. Also provided are methods for enhancing the transmucosal absorption and bioavailability of bioactive peptides and proteins using such compositions.

US Patent:

20050215475, Sep 29, 2005

Filed:

Jan 12, 2005

Appl. No.:

11/034706

Inventors:

John Ong - San Marcos CA, US
Robert Jennings - San Diego CA, US
Christopher Rhodes - San Diego CA, US
Gregg Stetsko - San Diego CA, US

International Classification:

A61K038/17

US Classification:

514012000

Abstract:

Provided are methods and compositions for enhancing the transmucosal absorption of bioactive peptides and proteins. More particularly, the invention provides compositions for enhancing the transmucosal absorption of bioactive peptides and proteins, such as exendin-4, PYY, PYY, and GLP-1 and their analogs and derivatives, wherein the compositions comprise an absorption enhancing mixture of a cationic polyamino acid, at least one additional absorption enhancing agent, and a buffer that is compatible with the polyamino acid. Also provided are methods for enhancing the transmucosal absorption and bioavailability of bioactive peptides and proteins using such compositions.

US Patent:

20080200383, Aug 21, 2008

Filed:

Apr 6, 2006

Appl. No.:

11/910723

Inventors:

Robert N. Jennings - San Diego CA, US
John T.H. Ong - San Marcos CA, US
Christopher A. Rhodes - San Diego CA, US
Gregg Stetsko - Incline Village NV, US
Steven J. Prestrelski - San Diego CA, US

Assignee:

Amylin Pharmaceuticals, Inc. - San Diego CA

International Classification:

A61K 38/22
A61P 3/10

US Classification:

514 12

Abstract:

The present disclosure is directed to stable pharmaceutical formulations and uses thereof.

US Patent:

20090069226, Mar 12, 2009

Filed:

Jan 12, 2005

Appl. No.:

11/628123

Inventors:

John Ong - San Diego CA, US
Robert Jennings - San Diego CA, US
Christopher Rhodes - San Diego CA, US
Gregg Stetsko - San Diego CA, US

Assignee:

Amylin Pharmaceuticals, Inc. - San Diego CA

International Classification:

A61K 38/17
A61K 38/02

US Classification:

514 12, 514 2

Abstract:

Provided are methods and compositions for enhancing the transmucosal absorption of bioactive peptides and proteins. More particularly, the invention provides compositions for enhancing the transmucosal absorption of bioactive peptides and proteins, such as exendin-4, PYY, PYY3-36, and GLP-1 and their analogs and derivatives, wherein the compositions comprise an absorption enhancing mixture of a cationic polyamino acid, at least one additional absorption enhancing agent, and a buffer that is compatible with the polyamino acid. Also provided are methods for enhancing the transmucosal absorption and bioavailability of bioactive peptides and proteins using such compositions.

US Patent:

20090291886, Nov 26, 2009

Filed:

May 5, 2008

Appl. No.:

12/115466

Inventors:

John Ong - San Marcos CA, US
Robert Jennings - San Diego CA, US
Christopher Rhodes - San Diego CA, US
Gregg Stetsko - San Diego CA, US

Assignee:

Amylin Pharmaceuticals, Inc. - San Diego CA

International Classification:

A61K 38/16

US Classification:

514 12

Abstract:

Provided are methods and compositions for enhancing the transmucosal absorption of bioactive peptides and proteins. More particularly, the invention provides compositions for enhancing the transmucosal absorption of bioactive peptides and proteins, such as exendin-4, PYY, PYY, and GLP-1 and their analogs and derivatives, wherein the compositions comprise an absorption enhancing mixture of a cationic polyamino acid and a buffer that is compatible with the polyamino acid. Also provided are methods for enhancing the transmucosal absorption and bioavailability of bioactive peptides and proteins using such compositions.

US Patent:

20110212138, Sep 1, 2011

Filed:

Sep 4, 2009

Appl. No.:

13/060225

Inventors:

Mary L. Houchin - Rockville MD, US
Robin H. Lee - San Diego CA, US
Hong Qi - San Diego CA, US
Greg Oehrtman - San Diego CA, US
Robert N. Jennings - San Diego CA, US
Scott H. Coleman - San Diego CA, US

International Classification:

A61K 9/00
A61K 38/00
A61K 38/22
A61K 38/28
A61K 38/38
A61K 31/60
A61K 31/135
A61P 3/10
A61P 3/08
A61P 3/00
A61P 3/04
A61P 3/06

US Classification:

424400, 514 48, 514 58, 514 59, 514 69, 514 74, 514159, 514649

Abstract:

The disclosure provides one-component, injectable, sustained release formulations which comprise microspheres containing active pharmaceutical ingredients (e.g., exenatide), wherein the microspheres are suspended in a non-aqueous carrier. The non-aqueous carrier can be an oil, a fractionated oil, triglycerides, diglycerides, monoglycerides, propylene glycol fatty acid diesters, and the like. The formulations offer distinct advantages of long shelf life for the stability and potency of the formulation and sustained release of active pharmaceutical ingredients to reduce the frequency of medication dosing and to increase patient compliance.

US Patent:

40625761, Dec 13, 1977

Filed:

May 10, 1976

Appl. No.:

5/684721

Inventors:

Robert Newton Jennings - San Diego CA
John Murray - San Diego CA
Donald Herbert Hartleben - San Diego CA

International Classification:

E05C 1918

US Classification:

292258

Abstract:

The device locks the sliding panel against horizontal and vertical movement. The device is secured on one of the upraised walls of the panel track by an eccentric that works in opposition to a support flange. The support flange carries slide stops to prevent the panel from sliding in its track. The vertical movement of the window out of the track is prevented by a lift stop comprising a flat spring secured in the upper track or lift stop elements on the support flange.